{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T05:31:12Z","timestamp":1790487072162,"version":"4.1.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001807","name":"FAPESP","doi-asserted-by":"crossref","award":["2005\/57746-8"],"award-info":[{"award-number":["2005\/57746-8"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001807","name":"FAPESP","doi-asserted-by":"crossref","award":["2008\/52049-5"],"award-info":[{"award-number":["2008\/52049-5"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001807","name":"FAPESP","doi-asserted-by":"crossref","award":["2011\/20135-2"],"award-info":[{"award-number":["2011\/20135-2"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003593","name":"CNPq","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Blood Cells, Molecules, and Diseases"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1016\/j.bcmd.2014.02.008","type":"journal-article","created":{"date-parts":[[2014,3,13]],"date-time":"2014-03-13T03:01:42Z","timestamp":1394679702000},"page":"47-55","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"title":["ApoptomiRs expression modulated by BCR\u2013ABL is linked to CML progression and imatinib resistance"],"prefix":"10.1016","volume":"53","author":[{"given":"A.F.","family":"Ferreira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.G.","family":"Moura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Tojal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Ambr\u00f3sio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Pinto-Sim\u00f5es","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Hamerschlak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.A.","family":"Calin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Ivan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.T.","family":"Covas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Kashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.A.","family":"Castro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcmd.2014.02.008_bb0005","first-page":"441","article-title":"Chronic myeloid leukemia as a model of disease evolution in human cancer","volume":"7","author":"Melo","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.bcmd.2014.02.008_bb0010","first-page":"2049","article-title":"BCR\u2013ABL tyrosine kinase activity regulates the expression of multiple genes implicated in the pathogenesis of chronic myeloid leukemia","volume":"60","author":"Deininger","year":"2000","journal-title":"Cancer Res."},{"key":"10.1016\/j.bcmd.2014.02.008_bb0015","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1590\/S0100-879X1999000900001","article-title":"The regulation of apoptotic cell death","volume":"32","author":"Amarante-Mendes","year":"1999","journal-title":"Braz. J. Med. Biol. Res."},{"key":"10.1016\/j.bcmd.2014.02.008_bb0020","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1046\/j.0902-4441.2003.00201.x","article-title":"Differences in BCL-X(L) expression and STAT5 phosphorylation in chronic myeloid leukaemia patients","volume":"72","author":"Gutierrez-Castellanos","year":"2004","journal-title":"Eur. J. Haematol."},{"key":"10.1016\/j.bcmd.2014.02.008_bb0025","doi-asserted-by":"crossref","first-page":"3303","DOI":"10.1182\/blood-2004-02-0749","article-title":"Identification of mcl-1 as a BCR\/ABL-dependent target in chronic myeloid leukemia: evidence for cooperative antileukemic effects of imatinib and mcl-1 antisense oligonucleotides","volume":"105","author":"Aichberger","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2014.02.008_bb0030","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1158\/1078-0432.CCR-06-2320","article-title":"From mRNA metabolism to cancer therapy: chronic myelogenous leukemia shows the way","volume":"13","author":"Perrotti","year":"2007","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bcmd.2014.02.008_bb0035","first-page":"169","article-title":"Chronic myelogenous leukemia: update on biology and treatment","volume":"13","author":"Faderl","year":"1999","journal-title":"Oncology"},{"key":"10.1016\/j.bcmd.2014.02.008_bb0040","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.2353\/ajpath.2007.061170","article-title":"MicroRNAs are aberrantly expressed in hypertrophic heart: do they play a role in cardiac hypertrophy?","volume":"170","author":"Cheng","year":"2007","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bcmd.2014.02.008_bb0045","doi-asserted-by":"crossref","first-page":"13944","DOI":"10.1073\/pnas.0506654102","article-title":"miR-15 and miR-16 induce apoptosis by targeting BCL2","volume":"102","author":"Cimmino","year":"2005","journal-title":"PNAS"},{"key":"10.1016\/j.bcmd.2014.02.008_bb0050","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1590\/S0100-879X2007001100003","article-title":"miRNA expression profiles in chronic lymphocytic and acute lymphocytic leukemia","volume":"40","author":"Zanette","year":"2007","journal-title":"Braz. J. Med. Biol. Res."},{"key":"10.1016\/j.bcmd.2014.02.008_bb0055","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1016\/j.ejca.2010.03.031","article-title":"miR signatures and the role of miRs in acute myeloid leukaemia","volume":"46","author":"Seca","year":"2010","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.bcmd.2014.02.008_bb0060","series-title":"Expression of Genes Involved in Cell Proliferation and Apoptosis in Chronic Lymphocytic Leukemia","author":"Careta","year":"2007"},{"key":"10.1016\/j.bcmd.2014.02.008_bb0065","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1038\/sj.cdd.4401210","article-title":"Bcr\u2013Abl1-mediated resistance to apoptosis is independent of constant tyrosine-kinase activity","volume":"10","author":"Bueno-da-Silva","year":"2003","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.bcmd.2014.02.008_bb0070","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1124\/mol.112.079889","article-title":"Molecular characteristics of CTA056, a novel interleukin-2-inducible T-cell kinase inhibitor that selectively targets malignant T cells and modulates oncomirs","volume":"82","author":"Guo","year":"2012","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bcmd.2014.02.008_bb0075","doi-asserted-by":"crossref","first-page":"35501","DOI":"10.1371\/journal.pone.0035501","article-title":"Downregulation of miR-31, miR-155, and miR-564 in chronic myeloid leukemia cells","volume":"7","author":"Rokah","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.bcmd.2014.02.008_bb0080","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s12079-011-0139-x","article-title":"MicroRNAs 130a\/130b are regulated by BCR\u2013ABL and downregulate expression of CCN3 in CML","volume":"5","author":"Suresh","year":"2011","journal-title":"J. Cell Commun. Signal."},{"key":"10.1016\/j.bcmd.2014.02.008_bb0085","doi-asserted-by":"crossref","first-page":"15524","DOI":"10.1073\/pnas.242606799","article-title":"Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia","volume":"99","author":"Calin","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bcmd.2014.02.008_bb0090","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1038\/modpathol.2012.95","article-title":"Reovirus-associated reduction of microRNA-let-7d is related to the increased apoptotic death of cancer cells in clinical samples","volume":"25","author":"Nuovo","year":"2012","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.bcmd.2014.02.008_bb0095","doi-asserted-by":"crossref","first-page":"6133","DOI":"10.1038\/sj.onc.1210436","article-title":"miR-29 regulates Mcl-1 protein expression and apoptosis","volume":"26","author":"Mott","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.bcmd.2014.02.008_bb0100","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1002\/hep.23380","article-title":"Effects of microRNA-29 on apoptosis, tumorigenicity, and prognosis of hepatocellular carcinoma","volume":"51","author":"Xiong","year":"2010","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.bcmd.2014.02.008_bb0105","doi-asserted-by":"crossref","first-page":"e26","DOI":"10.1038\/bcj.2011.24","article-title":"MicroRNA-146a and AMD3100, two ways to control CXCR4 expression in acute myeloid leukemias","volume":"1","author":"Spinello","year":"2011","journal-title":"Blood Cancer J."},{"issue":"9","key":"10.1016\/j.bcmd.2014.02.008_bb0110","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1007\/s10495-013-0854-2","article-title":"Alantolactone induces apoptosis in chronic myelogenous leukemia sensitive or resistant to imatinib through NF-\u03baB inhibition and Bcr\/Abl protein deletion","volume":"18","author":"Wei","year":"2013","journal-title":"Apoptosis"},{"key":"10.1016\/j.bcmd.2014.02.008_bb0115","doi-asserted-by":"crossref","first-page":"48267","DOI":"10.1371\/journal.pone.0048267","article-title":"BCL2A1a over-expression in murine hematopoietic stem and progenitor cells decreases apoptosis and results in hematopoietic transformation","volume":"7","author":"M\u00e9tais","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.bcmd.2014.02.008_bb0120","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1038\/onc.2008.466","article-title":"MYC-induced myeloid leukemogenesis is accelerated by all six members of the antiapoptotic BCL family","volume":"28","author":"Beverly","year":"2009","journal-title":"Oncogene"},{"key":"10.1016\/j.bcmd.2014.02.008_bb0125","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.bcp.2004.02.028","article-title":"In bcr\u2013abl-positive myeloid cells resistant to conventional chemotherapeutic agents, expression of Par-4 increases sensitivity to imatinib (STI571) and histone deacetylase-inhibitors","volume":"68","author":"Brieger","year":"2004","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bcmd.2014.02.008_bb0130","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/1476-4598-8-69","article-title":"MicroRNA expression profiling in imatinib-resistant chronic myeloid leukemia patients without clinically significant ABL1-mutations","volume":"8","author":"En\u00e9riz","year":"2009","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bcmd.2014.02.008_bb0135","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1038\/sj.leu.2402741","article-title":"Molecular and chromosomal mechanisms of resistance to imatinib (STI571) therapy","volume":"16","author":"Hochhaus","year":"2002","journal-title":"Leukemia"},{"key":"10.1016\/j.bcmd.2014.02.008_bb0140","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.3324\/haematol.2009.020636","article-title":"Micro-RNA response to imatinib mesylate in patients with chronic myeloid leukemia","volume":"95","author":"Flamant","year":"2010","journal-title":"Haematologica"},{"key":"10.1016\/j.bcmd.2014.02.008_bb0145","doi-asserted-by":"crossref","first-page":"12481","DOI":"10.1073\/pnas.0605298103","article-title":"NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses","volume":"103","author":"Taganov","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."}],"updated-by":[{"DOI":"10.1016\/j.bcmd.2015.08.005","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000}}],"container-title":["Blood Cells, Molecules, and Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S107997961400014X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S107997961400014X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T01:47:27Z","timestamp":1746150447000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S107997961400014X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6]]},"references-count":29,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["S107997961400014X"],"URL":"https:\/\/doi.org\/10.1016\/j.bcmd.2014.02.008","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/j.bcmd.2015.08.005","asserted-by":"object"}]},"ISSN":["1079-9796"],"issn-type":[{"value":"1079-9796","type":"print"}],"subject":[],"published":{"date-parts":[[2014,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ApoptomiRs expression modulated by BCR\u2013ABL is linked to CML progression and imatinib resistance","name":"articletitle","label":"Article Title"},{"value":"Blood Cells, Molecules, and Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcmd.2014.02.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}